Search research articles
Contact Us
Filters
Showing results (71-80 of 239) with videos related to
Page
of 24
Sort By:
Toxicology and Applied Pharmacology
|
July 12, 2011
Inhibition of soluble epoxide hydrolase contributes to the anti-inflammatory effect of antimicrobial triclocarban in a murine model
Jun-Yan Liu, Hong Qiu, Christophe Morisseau, et al.
The Canadian Veterinary Journal = La Revue Veterinaire Canadienne
|
July 2, 2010
Efficacy of dog-appeasing pheromone (DAP) for ameliorating separation-related behavioral signs in hospitalized dogs
Young-Mee Kim, Jong-Kyung Lee, A M Abd el-aty, et al.
Cancer Biology & Therapy
|
January 10, 2013
A novel p21 attenuator which is structurally related to sorafenib
Hiromi I Wettersten, Sung Hee Hwang, Cuiwen Li, et al.
American Journal of Physiology. Renal Physiology
|
November 8, 2014
Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy
Jinu Kim, Sang Pil Yoon, Myron L Toews, et al.
Journal of Medicinal Chemistry
|
December 28, 2020
Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products
Cheng-Peng Sun, Xin-Yue Zhang, Christophe Morisseau, et al.
Clinical and Experimental Pharmacology & Physiology
|
October 9, 2012
Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system
Sarka Varcabova, Zuzana Huskova, Herbert J Kramer, et al.
Journal of Alzheimer'S Disease : JAD
|
February 18, 2025
Inhibitors of soluble epoxide hydrolase and cGAS/STING repair defects in amyloid-β clearance underlying vascular complications of Alzheimer's disease
Milan Fiala, Bruce D Hammock, Sung Hee Hwang, et al.
Journal of Pharmaceutical Analysis
|
October 16, 2023
Quantification of soluble epoxide hydrolase inhibitors in experimental and clinical samples using the nanobody-based ELISA
Huiyi Yang, Meng Qi, Qiyi He, et al.
International Journal of Molecular Sciences
|
June 28, 2023
Aflatoxin B<sub>1</sub> Increases Soluble Epoxide Hydrolase in the Brain and Induces Neuroinflammation and Dopaminergic Neurotoxicity
Weicang Wang, Yuxin Wang, Karen M Wagner, et al.
The International Journal of Neuroscience
|
April 3, 2012
Normal diffusion-weighted MRI during the acute stage of central pontine myelinolysis
Suk Yun Kang, Hyeo-Il Ma, Young-Min Lim, et al.
Page
of 24
Search research articles
Search
Showing results (71-80 of 239) with videos related to
Sort By:
Page
of 24
Toxicology and Applied Pharmacology
|
July 12, 2011
Inhibition of soluble epoxide hydrolase contributes to the anti-inflammatory effect of antimicrobial triclocarban in a murine model
Jun-Yan Liu, Hong Qiu, Christophe Morisseau, et al.
The Canadian Veterinary Journal = La Revue Veterinaire Canadienne
|
July 2, 2010
Efficacy of dog-appeasing pheromone (DAP) for ameliorating separation-related behavioral signs in hospitalized dogs
Young-Mee Kim, Jong-Kyung Lee, A M Abd el-aty, et al.
Cancer Biology & Therapy
|
January 10, 2013
A novel p21 attenuator which is structurally related to sorafenib
Hiromi I Wettersten, Sung Hee Hwang, Cuiwen Li, et al.
American Journal of Physiology. Renal Physiology
|
November 8, 2014
Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy
Jinu Kim, Sang Pil Yoon, Myron L Toews, et al.
Journal of Medicinal Chemistry
|
December 28, 2020
Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products
Cheng-Peng Sun, Xin-Yue Zhang, Christophe Morisseau, et al.
Clinical and Experimental Pharmacology & Physiology
|
October 9, 2012
Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system
Sarka Varcabova, Zuzana Huskova, Herbert J Kramer, et al.
Journal of Alzheimer'S Disease : JAD
|
February 18, 2025
Inhibitors of soluble epoxide hydrolase and cGAS/STING repair defects in amyloid-β clearance underlying vascular complications of Alzheimer's disease
Milan Fiala, Bruce D Hammock, Sung Hee Hwang, et al.
Journal of Pharmaceutical Analysis
|
October 16, 2023
Quantification of soluble epoxide hydrolase inhibitors in experimental and clinical samples using the nanobody-based ELISA
Huiyi Yang, Meng Qi, Qiyi He, et al.
International Journal of Molecular Sciences
|
June 28, 2023
Aflatoxin B<sub>1</sub> Increases Soluble Epoxide Hydrolase in the Brain and Induces Neuroinflammation and Dopaminergic Neurotoxicity
Weicang Wang, Yuxin Wang, Karen M Wagner, et al.
The International Journal of Neuroscience
|
April 3, 2012
Normal diffusion-weighted MRI during the acute stage of central pontine myelinolysis
Suk Yun Kang, Hyeo-Il Ma, Young-Min Lim, et al.
Page
of 24